“Biological therapies improve quality of life in patients with nasal polyposis”

2023-05-26 19:09:38

On the occasion of the 109th National Congress of Sio, the Italian Society of Otorhinolaryngology and Head and Neck Surgery, taking place from 24 to 27 May in Milan, and on the sidelines of the Gsk meeting entitled “New frontiers in CRSwNP: precision therapy with mepolizumab”, focused on chronic rhinosinusitis with nasal polyposis, spoke Enrico Heffler, allergist and clinical immunologist and professor of Internal Medicine at Humanitas University in Milan.